Gold Pharma operates a state-of-the-art API and intermediates manufacturing facility in Atchutapuram, Visakhapatnam, India. Commencing operations in 2022, this facility serves as the manufacturing backbone for the company, featuring multi-capacity reactors, stringent regulatory alignment, and an export-oriented approach. It is seamlessly integrated with CVR Life Sciences’ R&D framework, ensuring a cohesive and efficient development pipeline.
Our manufacturing capabilities are built on a foundation of precision, compliance, and innovation. Every process within our facilities is meticulously aligned with global Good Manufacturing Practices (GMP), ensuring that quality is never compromised. From raw material procurement to large‑scale production and final product release, each stage is governed by validated procedures, rigorous quality checks, and continuous monitoring systems. This disciplined approach guarantees consistency, safety, and reliability in every batch we deliver, while reinforcing our commitment to meet and exceed international regulatory expectations.
At the core of our strength lies our deep knowledge of chemistry and proven expertise in handling complex, multi‑step reactions. Our teams are adept at designing and executing challenging synthetic routes, optimizing yields, and ensuring reproducibility across scales. This capability allows us to deliver APIs and intermediates that meet the highest standards of purity and performance. By combining scientific insight with practical execution, we transform intricate chemical processes into reliable, scalable solutions for global pharmaceutical partners.
Our vertical integration into Research and Development ensures seamless connectivity between innovation and manufacturing. Advanced R&D infrastructure enables us to scout new routes, develop efficient processes, and validate them for commercial application. This integration minimizes development timelines, enhances scalability, and ensures that every product benefits from continuous scientific refinement. By bridging laboratory innovation with industrial execution, we create a robust pipeline of APIs and generics that are both cost‑effective and globally competitive.
Supporting our expertise is a world‑class infrastructure equipped with advanced instrumentation and Class 100000 clean rooms. These facilities provide controlled environments that safeguard product integrity and guarantee the highest levels of purity. Our comprehensive equipment portfolio allows us to manage diverse reaction conditions and specialized processes with precision. Together, this infrastructure ensures that every batch we produce consistently meets stringent quality benchmarks, delivering materials that inspire confidence among partners and safeguard patient health worldwide.
